Alzai Health Corp. ALZIF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.10K | 0.00 | 19.50K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.10K | 0.00 | 19.50K | -- | -- |
| Cost of Revenue | 116.90K | 103.10K | 68.60K | 107.90K | 20.90K |
| Gross Profit | -86.80K | -103.10K | -49.10K | -107.90K | -20.90K |
| SG&A Expenses | 372.00K | 182.20K | 631.00K | 434.00K | 265.40K |
| Depreciation & Amortization | 3.70K | 3.60K | 3.10K | 2.60K | 2.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 697.90K | 490.90K | 1.08M | 658.90K | 408.60K |
| Operating Income | -667.80K | -490.90K | -1.06M | -658.90K | -408.60K |
| Income Before Tax | -713.70K | -535.30K | -1.06M | -674.80K | -392.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -713.70K | -535.30K | -1.06M | -674.80K | -392.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -713.70K | -535.30K | -1.06M | -674.80K | -392.60K |
| EBIT | -667.80K | -490.90K | -1.06M | -658.90K | -408.60K |
| EBITDA | -666.70K | -490.00K | -1.06M | -658.90K | -406.00K |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 59.74M | 53.32M | 53.09M | 51.43M | 47.62M |
| Average Diluted Shares Outstanding | 59.74M | 53.32M | 53.09M | 51.43M | 47.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |